Cargando…
Infrastructural capital in the Israeli vaccination campaign against COVID-19()
This article examines the Israeli vaccination campaign against COVID-19, focusing on the state's acquisition of the vaccines from the pharmaceutical company Pfizer. In December 2020, Israel signed an agreement with Pfizer to purchase enough doses to vaccinate its entire population. In the month...
Autor principal: | Tubi, Omri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081040/ https://www.ncbi.nlm.nih.gov/pubmed/35569233 http://dx.doi.org/10.1016/j.socscimed.2022.115022 |
Ejemplares similares
-
Vaccine Hesitancy and the Concept of Trust: An Analysis Based on the Israeli COVID-19 Vaccination Campaign
por: Freiman, Ori
Publicado: (2023) -
Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence
por: Gavish, Nir, et al.
Publicado: (2022) -
Eradicating ageism through social campaigns: An Israeli case study in the shadows of the COVID‐19 pandemic
por: Okun, Sarit, et al.
Publicado: (2022) -
Issues surrounding incentives and penalties for COVID-19 vaccination: The Israeli experience
por: Saban, Mor, et al.
Publicado: (2021) -
The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines
por: Rosen, Bruce, et al.
Publicado: (2022)